Skip to main content

Table 2 Premarket approvals with investigational device exemption trials 2000–2016

From: Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs

Number

Date

Sponsor

Device

1

April 20, 2016

Cartiva

Synthetic Cartilage Implant

2

February 19, 2015

Medtronic

DIAM Spinal Stabilization System

3

February 20, 2015

Vertiflex

Superion Spinous Process Spacer [16]

4

May 12, 2011

BioMimetic

Augment Bone Graft [6]

5

May 27, 2010

Medtronic

Amplify rhBMP-2 Matrix [7]

6

November 4, 2009

Zimmer Spine

Dynesys Spinal System [8]

7

August 19, 2009

Q-Med

Durolane [46]

8

August 18, 2009

DePuy Orthopaedics

CoMplete Acetabular Hip System [47]

9

March 31, 2009

Stryker Biotech

OP-1 Putty [48]

10

December 9, 2008

Genzyme

Synvisc One [49]

11

November 14, 2008

ReGen Biologics

Collagen Scaffold (CS)/Menaflex

12

July 15, 2008

FzioMed

Oxiplex/SP Gel [50]

13

July 17, 2007

Medtronic

Bryan Cervical Disc [51]

14

April 24, 2007

Link America

Scandinavian Total Ankle Replacement (STAR) System [52]

15

February 22, 2007

Corin USA

Cormet 2000 Hip Resurfacing System [53]

16

September 19, 2006

Medtronic

Prestige Cervical Disc System [29]

17

September 8, 2005

Smith & Nephew

Birmingham Hip Resurfacing System

18

August 31, 2004

St. Francis Medical

X STOP Interspinous Process Decompression System [30]

19

June 2, 2004

DePuy Spine

Charité Artificial Disc [28]

20

November 21, 2002

Wyeth

InductOs rhBMP-2/absorbable collagen sponge [57]

21

November 20, 2002

Independence

iBOT 3000 Mobility System [58]

22

January 10, 2002

Medtronic

InFUSE rhBMP-2/absorbable collagene sponge [59]

23

July 20, 2000

HealthTronic

OssaTron Lithotripter [4]

Number

Filing

Design

Type

Arms

Control

1

PMA (P150017)

RCT

Non-inferiority

2

Active

2

PMA (1400007)

RCT

Superiority

2

Usual care

3

PMA (P140004)

RCT

Non-inferiority

2

Active

4

PMA (P100006)

RCT

Non-inferiority

2

Active

5

PMA (P050036)

RCT

Non-inferiority

2

Active

6

PMA (P070031)

RCT

Non-inferiority

2

Active

7

PMA (P060013)

RCT

Superiority

2

Sham

8

PMA (P090002)

RCT

Non-inferiority

2

Active

9

PMA (P060021)

RCT

Non-inferiority

2

Active

10

PMA (P940015)

RCT

Superiority

2

Sham

11

510(k) (K082079)

RCT

Superiority

2

Active

12

PMA (P070023)

RCT

Superiority

2

Active

13

PMA (P060023)

RCT

Non-inferiority

2

Active

14

PMA (P050050)

RCT

Non-inferiority

2

Active

15

PMA (P050016)

Non-randomized

Non-inferiority

2

Active

16

PMA (P060018)

RCT

Non-inferiority

2

Active

17

PMA (P040033)

Observational

18

PMA (P040001)

RCT

Superiority

2

Usual care

19

PMA (P040006)

RCT

Non-inferiority

2

Active

20

PMA (P000054)

RCT

Superiority

2

Active

21

PMA (P020033)

Observational

Crossover

2

Usual care

22

PMA (P000058)

RCT

Non-inferiority

2

Active

23

PMA (P990086)

RCT

Superiority

2

Sham

  1. IDE investigational device exemption, PMA premarket approval, RCT randomized controlled trial